S&P 5007,736.52▲1.8% Nasdaq26,584.99▲2.6% Dow54,085.88▲1.7% Russell 2K3,036.98▲1.9% 10-Yr4.63%−6bp VIX16.50+0.64 WTI$75.32▼6.2% Gold$4,133.60▲2.5% EUR/USD1.153▼0.1% BTC$64,170▲0.2% Nikkei63,755▼0.9%
At close · Tue, Aug 4, 2026
Daily Market Updates.

Earnings

HomeEarningsResultsCVS tops estimates and raises guidance as insurance un…

CVS tops estimates and raises guidance as insurance unit improves

CVS also said it will partner with Eli Lilly to make Zepbound and Foundayo available to eligible patients through the CVS Health app.

CVS reported results that topped estimates and said it is raising its guidance, pointing to continued improvement in its insurance business, according to CNBC Markets.

Alongside the earnings and outlook update, the company announced a new collaboration with Eli Lilly.

Under the deal, Zepbound and Foundayo will be accessible to eligible patients through the CVS Health app, CNBC Earnings reported.

More like this

Sources

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.